Safiye Nur Yildiz

Safiye Nur Yildiz

Auto-generated profile, based on publicly available information

Safiye Nur Yildiz

Department of Biomedical Engineering, Necmettin Erbakan University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2024 in Medcomm
Verified
Journal Article
Open access
SYSafiye Nur Yildiz
Safiye Nur Yildiz
MEMaliheh Entezari
Maliheh Entezari
MPMahshid Deldar Abad Paskeh
Mahshid Deldar Abad Paskeh
SMSepideh Mirzaei
Sepideh Mirzaei
AKAlireza Kalbasi
Alireza Kalbasi
Yavuz Nuri ErtasYavuz Nuri Ertas
Yavuz Nuri Ertas
Nonviral vectors, such as liposomes, offer potential for targeted gene delivery in cancer therapy. Liposomes, composed of phospholipid vesicles, have demonstrated efficacy as nanocarriers for genetic tools, addressing the limitations of off‐targeting and degradation commonly associated with traditional gene therapy approaches. Due to their biocompatibility, stability, and tunable physicochemical properties, they offer potential in overcoming the challenges associated with gene therapy, such as low transfection efficiency and poor stability in biological fluids. Despite these advancements, there remains a gap in understanding the optimal utilization of nanoliposomes for enhanced gene delivery in cancer treatment. This review delves into the present state of nanoliposomes as carriers for genetic tools in cancer therapy, sheds light on their potential to safeguard genetic payloads and facilitate cell internalization alongside the evolution of smart nanocarriers for targeted delivery. The challenges linked to their biocompatibility and the factors that restrict their effectiveness in gene delivery are also discussed along with exploring the potential of nanoliposomes in cancer gene therapy strategies by analyzing recent advancements and offering future directions.

13 February 2024 in Biomedical Materials
Verified
Journal Article
Open access
SYSafiye Nur Yildiz
Safiye Nur Yildiz
TATugba Sezgin Arslan
Tugba Sezgin Arslan
YAYavuz Emre ARSLAN
Yavuz Emre ARSLAN
Therapeutic angiogenesis is pivotal in creating effective tissue-engineered constructs that deliver nutrients and oxygen to surrounding cells. Hence, biomaterials that promote angiogenesis can enhance the efficacy of various medical treatments, encompassing tissue engineering, wound healing, and drug delivery systems. Considering these, we propose a rapid method for producing composite silicon-boron-wool keratin/jellyfish collagen (Si-B-WK/JFC) inorganic-organic biohybrid films using sol-gel reactions. In this approach, reactive tetraethyl orthosilicate and boric acid (pKa ⩾ 9.24) were used as silicon and boron sources, respectively, and a solid-state gel was formed through the condensation reaction of these reactive groups with the keratin/collagen mixture. Once the resulting gel was thoroughly suspended in water, the films were prepared by a casting/solvent evaporation methodology. The fabricated hybrid films were characterized structurally and mechanically. In addition, angiogenic characteristics were determined by the in ovo chick chorioallantoic membrane assay, which revealed an increased vascular network within the Si-B-WK/JFC biohybrid films. In conclusion, it is believed that Si-B-WK/JFC biohybrid films with mechanical and pro-angiogenic properties have the potential to be possessed in soft tissue engineering applications, especially wound healing.

11 February 2026 in Journal of Adhesion Science and Technology
Verified
Journal Article
Closed access
BÜBayram Ünal
Bayram Ünal
MÖMuhammed İhsan Özgün
Muhammed İhsan Özgün
SYSafiye Nur Yıldız
Safiye Nur Yıldız
MEMürsel Ekrem
Mürsel Ekrem